FDA finalizes guidance on over-the-counter antimicrobials for veterinary use

Ultimately, the US Food and Drug Administration’s (FDA) finalized guidance for industry GFI #263 is all about antimicrobial stewardship. Released on June 10, GFI #263 from the FDA Center for Veterinary Medicine (CVM) outlines a two-year implementation period for animal drug manufacturers to voluntarily change the marketing status of some over-the-counter (OTC) antimicrobial drugs. The voluntary labeling changes…